State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

Corina Biagioni; Gabriela Tirado-Conte; Josep Rodés-Cabau; Nicola Ryan; Enrico Cerrato; Tamim M Nazif; Helene Eltchaninoff; Lars Sondergaard; Henrique B Ribeiro; Marco Barbanti; Fabian Nietlispach; Peter De Jaegere; Pierfrancesco Agostoni; Ramiro Trillo; Pilar Jiménez-Quevedo; Fabrizio D'Ascenzo; Olaf Wendler; Gabriel Maluenda; Mao Chen; Corrado Tamburino; Carlos Macaya; Martin B Leon; Luis Nombela-Franco

State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

Corina Biagioni, Gabriela Tirado-Conte, Josep Rodés-Cabau, Nicola Ryan, Enrico Cerrato, Tamim M Nazif, Helene Eltchaninoff, Lars Sondergaard, Henrique B Ribeiro, Marco Barbanti, Fabian Nietlispach, Peter De Jaegere, Pierfrancesco Agostoni, Ramiro Trillo, Pilar Jiménez-Quevedo, Fabrizio D'Ascenzo, Olaf Wendler, Gabriel Maluenda, Mao Chen, Corrado TamburinoCarlos Macaya, Martin B Leon, Luis Nombela-Franco

Institut for Klinisk Medicin

Abstract

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients. OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries. METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n ≤ 41), rest of Europe (n ≤ 105), and rest of the world (n ≤ 104). RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-Antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months). CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results. TAVI TAVR aortic valve disease transcatheter valve implantation Spain Europe survey.

Originalsprog	Engelsk
Tidsskrift	Journal of Invasive Cardiology
Vol/bind	30
Udgave nummer	8
Sider (fra-til)	301-309
ISSN	1042-3931
Status	Udgivet - aug. 2018

Adgang til dokumentet

https://www.invasivecardiology.com/articles/state-transcatheter-aortic-valve-implantation-spain-versus-europe-and-non-european

Citationsformater

Biagioni, C., Tirado-Conte, G., Rodés-Cabau, J., Ryan, N., Cerrato, E., Nazif, T. M., Eltchaninoff, H., Sondergaard, L., Ribeiro, H. B., Barbanti, M., Nietlispach, F., De Jaegere, P., Agostoni, P., Trillo, R., Jiménez-Quevedo, P., D'Ascenzo, F., Wendler, O., Maluenda, G., Chen, M., ... Nombela-Franco, L. (2018). State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. Journal of Invasive Cardiology, 30(8), 301-309. https://www.invasivecardiology.com/articles/state-transcatheter-aortic-valve-implantation-spain-versus-europe-and-non-european

Biagioni, C, Tirado-Conte, G, Rodés-Cabau, J, Ryan, N, Cerrato, E, Nazif, TM, Eltchaninoff, H, Sondergaard, L, Ribeiro, HB, Barbanti, M, Nietlispach, F, De Jaegere, P, Agostoni, P, Trillo, R, Jiménez-Quevedo, P, D'Ascenzo, F, Wendler, O, Maluenda, G, Chen, M, Tamburino, C, Macaya, C, Leon, MB & Nombela-Franco, L 2018, 'State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries', Journal of Invasive Cardiology, bind 30, nr. 8, s. 301-309. <https://www.invasivecardiology.com/articles/state-transcatheter-aortic-valve-implantation-spain-versus-europe-and-non-european>

@article{f7be775a006741e6a637d2bda70bc764,

title = "State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries",

abstract = "BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients. OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries. METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n ≤ 41), rest of Europe (n ≤ 105), and rest of the world (n ≤ 104). RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-Antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months). CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results. TAVI TAVR aortic valve disease transcatheter valve implantation Spain Europe survey.",

keywords = "Aged, Aged, 80 and over, Aortic Valve/surgery, Aortic Valve Stenosis/diagnosis, Echocardiography, Transesophageal, Europe, Female, Humans, Male, Patient Selection, Risk Factors, Spain, Transcatheter Aortic Valve Replacement/statistics & numerical data, United States",

author = "Corina Biagioni and Gabriela Tirado-Conte and Josep Rod{\'e}s-Cabau and Nicola Ryan and Enrico Cerrato and Nazif, {Tamim M} and Helene Eltchaninoff and Lars Sondergaard and Ribeiro, {Henrique B} and Marco Barbanti and Fabian Nietlispach and {De Jaegere}, Peter and Pierfrancesco Agostoni and Ramiro Trillo and Pilar Jim{\'e}nez-Quevedo and Fabrizio D'Ascenzo and Olaf Wendler and Gabriel Maluenda and Mao Chen and Corrado Tamburino and Carlos Macaya and Leon, {Martin B} and Luis Nombela-Franco",

year = "2018",

month = aug,

language = "English",

volume = "30",

pages = "301--309",

journal = "Journal of Invasive Cardiology",

issn = "1042-3931",

publisher = "H M P Communications, LLC",

number = "8",

}

TY - JOUR

T1 - State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

AU - Biagioni, Corina

AU - Tirado-Conte, Gabriela

AU - Rodés-Cabau, Josep

AU - Ryan, Nicola

AU - Cerrato, Enrico

AU - Nazif, Tamim M

AU - Eltchaninoff, Helene

AU - Sondergaard, Lars

AU - Ribeiro, Henrique B

AU - Barbanti, Marco

AU - Nietlispach, Fabian

AU - De Jaegere, Peter

AU - Agostoni, Pierfrancesco

AU - Trillo, Ramiro

AU - Jiménez-Quevedo, Pilar

AU - D'Ascenzo, Fabrizio

AU - Wendler, Olaf

AU - Maluenda, Gabriel

AU - Chen, Mao

AU - Tamburino, Corrado

AU - Macaya, Carlos

AU - Leon, Martin B

AU - Nombela-Franco, Luis

PY - 2018/8

Y1 - 2018/8

N2 - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients. OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries. METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n ≤ 41), rest of Europe (n ≤ 105), and rest of the world (n ≤ 104). RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-Antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months). CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results. TAVI TAVR aortic valve disease transcatheter valve implantation Spain Europe survey.

AB - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients. OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries. METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n ≤ 41), rest of Europe (n ≤ 105), and rest of the world (n ≤ 104). RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-Antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months). CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results. TAVI TAVR aortic valve disease transcatheter valve implantation Spain Europe survey.

KW - Aged

KW - Aged, 80 and over

KW - Aortic Valve/surgery

KW - Aortic Valve Stenosis/diagnosis

KW - Echocardiography, Transesophageal

KW - Europe

KW - Female

KW - Humans

KW - Male

KW - Patient Selection

KW - Risk Factors

KW - Spain

KW - Transcatheter Aortic Valve Replacement/statistics & numerical data

KW - United States

M3 - Journal article

C2 - 30068785

SN - 1042-3931

VL - 30

SP - 301

EP - 309

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

IS - 8

ER -

State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater